GSM4475959 |
Patient 3 Peripheral blood mononuclear cells SoluCortef |
GSM4475960 |
Patient 4 Peripheral blood mononuclear cells placebo |
GSM4475961 |
Patient 4 Peripheral blood mononuclear cells SoluCortef |
GSM4475962 |
Patient 6 Peripheral blood mononuclear cells placebo |
GSM4475963 |
Patient 6 Peripheral blood mononuclear cells SoluCortef |
GSM4475964 |
Patient 7 Peripheral blood mononuclear cells placebo |
GSM4475965 |
Patient 7 Peripheral blood mononuclear cells SoluCortef |
GSM4475966 |
Patient 8 Peripheral blood mononuclear cells placebo |
GSM4475967 |
Patient 8 Peripheral blood mononuclear cells SoluCortef |
GSM4475968 |
Patient 9 Peripheral blood mononuclear cells placebo |
GSM4475969 |
Patient 9 Peripheral blood mononuclear cells SoluCortef |
GSM4475970 |
Patient 10 Peripheral blood mononuclear cells placebo |
GSM4475971 |
Patient 10 Peripheral blood mononuclear cells SoluCortef |
GSM4475972 |
Patient 11 Peripheral blood mononuclear cells placebo |
GSM4475973 |
Patient 11 Peripheral blood mononuclear cells SoluCortef |
GSM4475974 |
Patient 1 Adipose Tissue placebo |
GSM4475975 |
Patient 1 Adipose Tissue SoluCortef |
GSM4475976 |
Patient 2 Adipose Tissue placebo |
GSM4475977 |
Patient 2 Adipose Tissue SoluCortef |
GSM4475978 |
Patient 3 Adipose Tissue placebo |
GSM4475979 |
Patient 3 Adipose Tissue SoluCortef |
GSM4475980 |
Patient 4 Adipose Tissue placebo |
GSM4475981 |
Patient 4 Adipose Tissue SoluCortef |
GSM4475982 |
Patient 6 Adipose Tissue placebo |
GSM4475983 |
Patient 6 Adipose Tissue SoluCortef |
GSM4475984 |
Patient 7 Adipose Tissue placebo |
GSM4475985 |
Patient 7 Adipose Tissue SoluCortef |
GSM4475986 |
Patient 8 Adipose Tissue placebo |
GSM4475987 |
Patient 8 Adipose Tissue SoluCortef |
GSM4475988 |
Patient 9 Adipose Tissue placebo |
GSM4475989 |
Patient 9 Adipose Tissue SoluCortef |
GSM4475990 |
Patient 10 Adipose Tissue placebo |
GSM4475991 |
Patient 10 Adipose Tissue SoluCortef |
GSM4475992 |
Patient 11 Adipose Tissue placebo |
GSM4475993 |
Patient 11 Adipose Tissue SoluCortef |